Galectin-7 serum levels are altered prior to the onset of pre-eclampsia

E Menkhorst1, K Koga2, M Van Sinderen1

  • 1Embryo Implantation Laboratory, MIMR-PHI (Prince Henry's Institute of Medical Research) Clayton, PO Box 5152, Clayton 3168, VIC, Australia; Monash University, Clayton, VIC, Australia.

Placenta
|February 19, 2014
PubMed

Galectins regulate many cell functions important for placental development, however, the localization and role of galectin-7 is unknown. We hypothesized galectin-7 would be expressed by the placenta and detected in serum. Galectin-7 immunolocalized to syncytiotrophoblast, extravillous trophoblast and glandular epithelium in 1st trimester placenta/decidua and to syncytiotrophoblast and endothelial cells in term placenta, but in pre-eclamptic placentas endothelial staining was absent. Galectin-7 serum concentration was significantly elevated in women (weeks 10-12 and 17-20) who subsequently developed pre-eclampsia compared to women with healthy pregnancies. Galectin-7 is a promising prospective serum biomarker for pre-eclampsia and likely has important functions in placentation.

Related Concept Videos